Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of subcutaneous afamelanotide implants in mild to moderate acne vulgaris
2009-018024-15Phase 2Completed
- Sponsor
- Clinuvel Pharmaceuticals
- Start
- Feb 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Afamelanotide in acne vulgaris (2 arms), sponsored by Clinuvel Pharmaceuticals. Primary endpoint: Primary efficacy endpoint. Started Feb 2010; status: completed.
02
Drugs
Afamelanotide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2009-018024-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018024-15.